Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
2.000
-0.250 (-11.11%)
At close: Aug 16, 2024, 4:00 PM
2.080
+0.080 (4.00%)
After-hours: Aug 16, 2024, 7:59 PM EDT
Citius Oncology Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
TTM
| Sep 30, 2023 | Sep 30, 2022 |
Prepaid Expenses | 8.91 | 7.73 | 2.69 |
Total Current Assets | 8.91 | 7.73 | 2.69 |
Long-Term Deferred Charges | 40 | 40 | 40 |
Accounts Payable | 0.5 | 1.29 | 0.09 |
Accrued Expenses | 27.12 | 19.76 | 5.75 |
Total Current Liabilities | 27.62 | 21.05 | 5.85 |
Long-Term Deferred Tax Liabilities | 1.44 | 1.15 | 0.58 |
Common Stock | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 47.53 | 43.66 | 41.69 |
Retained Earnings | -27.69 | -18.13 | -5.43 |
Total Liabilities & Equity | 48.91 | 47.73 | 42.69 |
Filing Date Shares Outstanding | 67.5 | 67.5 | 67.5 |
Total Common Shares Outstanding | 67.5 | 67.5 | 67.5 |
Working Capital | -18.71 | -13.31 | -3.16 |
Book Value Per Share | 0.29 | 0.38 | 0.54 |
Tangible Book Value | 19.85 | 25.54 | 36.27 |
Tangible Book Value Per Share | 0.29 | 0.38 | 0.54 |
Source: S&P Capital IQ. Standard template.
Financial Sources.